Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ETN | GEV |
|---|---|---|
| Price | $437.76 | $953.50 |
| Change today | ▼ 0.23% | ▲ 0.18% |
| Market cap | $170.03B | $253.95B |
| Return, 3 months | +8.5% | -9.8% |
| Return, year to date | +38.6% | +46.2% |
| Return, 1 year | +18.9% | +51.9% |
| P/E (TTM) | 44.4 | 27.3 |
| P/B | 8.4 | 21.2 |
| P/E percentile vs own 5y | 95th | 13th |
| Dividend yield | 0.98% | 0.21% |
| Revenue growth (YoY, latest qtr) | +21.4% | +21.9% |
| Net profit growth (YoY) | -16.2% | +31.9% |
| Gross margin | 35.9% | 20.2% |
| Operating margin | 17.7% | 4.4% |
| Net margin | 12.8% | 23.0% |
| Return on equity | 19.7% | 91.5% |
| Analyst target vs. price | +16.5% | +31.1% |
| Analyst buy share | 100% | 89% |
| RSI (14) | 59 | 49 |
| 30-day volatility | 42.6% | 47.5% |
| Max drawdown, 1 year | -18.3% | -25.5% |
| Trend read | Strong uptrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.